Ji Jiafu
季加孚
Professor of Surgery; Chief Expert, Gastrointestinal Cancer Center; Director, Department of Surgery
Gastric cancer surgery, D2 lymphadenectomy, perioperative integrated treatment for gastric cancer, laparoscopic gastrectomy, and translational gastrointestinal oncology(胃癌外科、D2淋巴结清扫、胃癌围手术期综合治疗、腹腔镜胃癌手术与胃肠肿瘤转化研究)
400 Gastric and gastrointestinal cancer surgery performed personally / year
(bjcancer.org.cn)Leadership & Positions
- Chief Expert, Gastrointestinal Cancer Center, Peking University Cancer Hospital
- Director, Department of Surgery, Peking University Cancer Hospital
- Former President, Peking University Cancer Hospital
- Former President, International Gastric Cancer Association (IGCA)
- Director, Peking University Cancer Research Center
Medical School
Inner Mongolia Medical College (1982)
Graduate
Master of Medicine in Oncology; PhD in Oncology; DrPH, Beijing Medical University; Cardiff University; Johns Hopkins University
Fellowships & Training
Stanford University — Postdoctoral research in oncology (United States)
Languages
Notable Publications
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
The Lancet (2012) — co-author
PubMed/DOIAssessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.
JAMA Surgery (2019) — co-author
PubMed/DOIPerioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.
The Lancet Oncology (2025) — co-author
PubMed/DOIPioneering Contributions
- Pioneered a modularized D2 gastrectomy approach that breaks the operation into 12 standardized modules, helping reduce national D2 gastrectomy mortality in China to 0.24%.
- Helped establish perioperative integrated treatment pathways for locally advanced gastric cancer, including CapOX-based adjuvant and perioperative strategies incorporated into practice-changing studies.
- Built and led a comprehensive gastric cancer prevention and treatment system integrating surgery, systemic therapy, AI-assisted diagnosis, and translational biobanking research.
Sources — Ji Jiafu
- https://gb.bjcancer.org.cn:807/Html/News/Articles/1000209.html—Official English title, current roles, IGCA former president status, training summary(accessed Apr 16, 2026)
- https://www.bjmu.edu.cn/zggcyys/dba325a73a5b4ed2a568e1c3f037d6ea.htm—Official Chinese biography, current affiliation, years at Peking University Cancer Hospital(accessed Apr 16, 2026)
- https://www.pku.edu.cn/details/3358.html—Official Chinese biography, current leadership roles, award and profile confirmation(accessed Apr 16, 2026)
- https://www.bjcancer.org.cn/Html/Departments/Main/Index_1000082.html—Official department/laboratory context, gastric cancer translational research leadership, publication volume context(accessed Apr 16, 2026)
- https://www.bjcancer.org/Html/Doctors/Main/Index_31001.html—Official Chinese doctor profile, current title and specialty description(accessed Apr 16, 2026)
- https://www.haodf.com/doctor/5997.html—Secondary source for training chronology and gastric cancer subspecialty years(accessed Apr 16, 2026)
- https://www.bjcancer.org.cn/Html/News/Articles/1000203.html—Official hospital feature stating his annual personal surgical volume returned to about 400 cases after stepping down as president, plus practice-duration narrative and D2 modularization impact(accessed Apr 16, 2026)
- https://www.sohu.com/a/1000592227_121118853—Secondary mirror of the same long-form profile; corroborates the official hospital feature on annual personal surgical volume(accessed Apr 16, 2026)
- https://www.nature.com/articles/d42473-019-00252-y—Hospital English naming, D2 modularization, D2 mortality figure, CapOX and biobank context(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/22226517/—Publication verification for CLASSIC trial(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/31553463/—Publication verification for laparoscopic distal gastrectomy randomized trial(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/39952264/—Publication verification for RESOLVE final report(accessed Apr 16, 2026)
Request a case review with Ji Jiafu
Ji Jiafu practices at Peking University Cancer Hospital in Beijing.
Request Case Review